Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adaptive exchange sustains cullin-RING ubiquitin ligase networks and proper licensing of DNA replication. | Proc Natl Acad Sci U S A | 2022 | 36037385 | PubTator, text mining | PubMed |
| Identification and Validation of Three Hub Genes Involved in Cell Proliferation and Prognosis of Castration-Resistant Prostate Cancer. | Oxid Med Cell Longev | 2022 | 36035209 | PubTator, text mining | PubMed |
| Mammalian Resilience Revealed by a Comparison of Human Diseases and Mouse Models Associated With DNA Helicase Deficiencies. | Front Mol Biosci | 2022 | 36032672 | PubTator, text mining | PubMed |
| Human Papillomavirus 16 E6 and E7 Oncoproteins Alter the Abundance of Proteins Associated with DNA Damage Response, Immune Signaling and Epidermal Differentiation. | Viruses | 2022 | 36016386 | PubTator, text mining | PubMed |
| Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing. | Vaccines (Basel) | 2022 | 36016137 | PubTator, text mining | PubMed |
| The Chromatin Remodeler HELLS: A New Regulator in DNA Repair, Genome Maintenance, and Cancer. | Int J Mol Sci | 2022 | 36012581 | PubTator, text mining | PubMed |
| Meier-Gorlin Syndrome: Clinical Misdiagnosis, Genetic Testing and Functional Analysis of ORC6 Mutations and the Development of a Prenatal Test. | Int J Mol Sci | 2022 | 36012502 | PubTator, text mining | PubMed |
| Predictive Biomarkers of Response to Neoadjuvant Chemotherapy in Breast Cancer: Current and Future Perspectives for Precision Medicine. | Cancers (Basel) | 2022 | 36010869 | PubTator, text mining | PubMed |
| Exploring the Novel Computational Drug Target and Associated Key Pathways of Oral Cancer. | Curr Issues Mol Biol | 2022 | 36005140 | PubTator, text mining | PubMed |
| Integrated analysis of anti-tumor roles of BAP1 in osteosarcoma. | Front Oncol | 2022 | 36003792 | PubTator, text mining | PubMed |
| Identification of Novel Therapeutic Candidates Against SARS-CoV-2 Infections: An Application of RNA Sequencing Toward mRNA Based Nanotherapeutics. | Front Microbiol | 2022 | 35983322 | PubTator, text mining | PubMed |
| The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles. | Front Immunol | 2022 | 35967413 | PubTator, text mining | PubMed |
| Integrated analysis of multiple bioinformatics studies to identify microRNA-target gene-transcription factor regulatory networks in retinoblastoma. | Transl Cancer Res | 2022 | 35966326 | PubTator, text mining | PubMed |
| Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation. | Cancer Manag Res | 2022 | 35958947 | PubTator, text mining | PubMed |
| Transcriptome Analysis of the Anti-Proliferative Effects of Ginsenoside Rh3 on HCT116 Colorectal Cancer Cells. | Molecules | 2022 | 35956952 | PubTator, text mining | PubMed |
| Identification of Novel Regulators of Radiosensitivity Using High-Throughput Genetic Screening. | Int J Mol Sci | 2022 | 35955908 | PubTator, text mining | PubMed |
| Identification of potential key molecules and signaling pathways for psoriasis based on weighted gene co-expression network analysis. | World J Clin Cases | 2022 | 35949853 | PubTator, text mining | PubMed |
| PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma. | Biomed Res Int | 2022 | 35941968 | PubTator, text mining | PubMed |
| A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma. | Front Oncol | 2022 | 35936736 | PubTator, text mining | PubMed |
| A Novel Identified Long Intergenic Noncoding RNA, LINC01574, Contributes to Breast Cancer Deterioration via the Regulation of miR-6745/TTYH3 Axis. | J Immunol Res | 2022 | 35935583 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=26